B 128 , 16681679 (2024)
Simultaneously, ROS activates intracellular REDOX signals, such as proto-oncogene tyrosine-protein kinase Src (c-Src), Protein tyrosine kinase 2 (Pyk2), extracellular signal-regulated kinases (ERKs) 1/2 (ERK1/2), and big mitogen-activated protein kinase 1 (BmK1) [61]
Opportunities in the GLP-1 analogues market are abundant, particularly in expanding therapeutic applications, strategic collaborations, mergers, and acquisitions are reshaping the competitive landscape, while the increasing acceptance of GLP-1 therapies for chronic weight management is opening new revenue streams
brand names are mentioned for identification only, not promotion
These changes are analysed as possible harbingers of a broader transition toward sustainable and equitable spatial practices